The present invention provides compositions and methods for diagnosing and treating diabetes and insulin resistance. In particular, the invention provides methods of identifying modulators of the polynucleotides or polypeptides of the invention and using those modulators to treat diabetes, as well as methods of diagnosing diabetes by measuring the levels of the polynucleotides or polypeptides of the invention in a patient.

 
Web www.patentalert.com

> Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof

~ 00351